Status:
COMPLETED
COVID-19 Vaccination Willingness in Older Adults Based on Self-determination Theory
Lead Sponsor:
Jing-Shan Deng
Conditions:
Old Age; Debility
Vaccine Hesitancy
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Introduction: The COVID-19 vaccine is an effective measure for preventing and controlling COVID-19 epidemics, and the World Health Organization lists older adults as a high-priority group for COVID-19...
Detailed Description
1. Study design and data collection This class pilot study will be conducted in September 2023 at a nursing home in Taizhou, China. This study has been approved by the Ethics Committee of Taizhou Hosp...
Eligibility Criteria
Inclusion
- (1) ≥ 60 years of age; (2) had not previously been vaccinated with a COVID-19 vaccine, or had not yet received their fourth booster dose of the vaccine; and (3) had the ability to communicate verbally and volunteered to participate in the survey.
Exclusion
- (1) contraindications to vaccination; (2) communication disorders; and (3) unwillingness to participate.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2023
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT06575114
Start Date
September 1 2023
End Date
November 17 2023
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taizhou Hospital
Taizhou, Linhai, China, 317000